Terumo Corp. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
467,359
489,506
525,026
514,164
587,775
599,481
Cost of Goods Sold (COGS) incl. D&A
225,348
233,480
240,125
252,905
282,146
287,278
Gross Income
242,011
256,026
284,901
261,259
305,629
312,203
SG&A Expense
176,723
188,570
203,198
170,712
198,659
209,477
EBIT
65,288
67,456
81,703
-
106,970
102,726
Unusual Expense
10,569
6,001
1,107
9,061
794
525
Non Operating Income/Expense
861
3,344
3,274
4,598
591
274
Interest Expense
1,542
1,254
1,395
2,123
2,250
2,051
Pretax Income
52,907
64,046
76,920
74,881
106,630
102,709
Income Tax
18,781
25,576
26,290
19,989
15,429
23,422
Consolidated Net Income
34,126
38,470
50,630
54,891
91,201
79,287
Net Income
34,096
38,470
50,676
55,002
91,295
79,470
Net Income After Extraordinaries
34,096
38,470
50,676
55,002
91,295
79,470
Net Income Available to Common
34,096
38,470
50,676
55,003
91,295
79,470
EPS (Basic)
89.78
101.33
135.13
152.30
259.12
108.70
Basic Shares Outstanding
380
380
375
361
352
731
EPS (Diluted)
89.78
99.12
126.36
142.75
242.06
104.97
Diluted Shares Outstanding
380
388
401
387
378
758
EBITDA
105,169
108,148
126,377
125,018
149,005
146,761
Non-Operating Interest Income
459
566
665
497
745
1,397
Minority Interest Expense
30
-
46
111
94
183
Equity in Affiliates (Pretax)
132
65
328
377
218
162

About Terumo

View Profile
Address
2-44-1 Hatagaya
Tokyo Tokyo 151
Japan
Employees -
Website http://www.terumo.co.jp
Updated 07/08/2019
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: General Hospital, Cardiac & Vascular, and Blood Management. The General Hospital segment produces, supplies, leases, and sells hospital equipment, pharmaceutical, home medical treatment, and peritoneal dialysis and diabetes-related products.